Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say - Reuters
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNRXcwd2ZTOXFZNXBqRlU5ZERTQkVXYW1BZDFpZFpNOXVEdEk1V3pDUEdpa0FadURxcGYtMVNjRHRBSkxoWDdxcWtBcERNVUdaYkU1d1lCWlFMT1dkX3pHOVp1dnUtSko3aERhaDh5UElCd0RlcWpOQmIwNVdHbmJiUWQyZjNOQlY3QUhRWHV1N3h1QnFNdUhVemo2UkltZF9NeklhWjRmNWVuZ2ZfUEJ2Z2dmVnR3Z29N?oc=5" target="_blank">Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say</a> <font color="#6f6f6f">Reuters</font>
Dr Reddy's Laboratories plans to launch its generic semaglutide injection, potentially named Obeda, in India by March 2026, following the patent expiry of semaglutide. The company aims to price it competitively, potentially up to 60% below the branded product.
Dr Reddy's Laboratories has applied to trademark the brand name 'Obeda' for its upcoming generic version of semaglutide, the active ingredient in Novo Nordisk's Ozempic. The launch is anticipated in March 2026, coinciding with the patent expiry of semaglutide in India.
Similar Stories
Related coverage based on topic and tags
UK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
June 11, 2026 at 08:22 PMWeight-loss drug Wegovy to be available in pill form in UK for first time
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
June 11, 2026 at 03:00 PMDexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - Reuters
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study Reuters
June 6, 2026 at 06:50 PMNovo Nordisk flags patient data breach from some clinical trials in cyberattack - Reuters
Novo Nordisk flags patient data breach from some clinical trials in cyberattack Reuters
June 11, 2026 at 09:55 PMHeart drug developer Kardigan targets $1.4 billion valuation in US IPO - Reuters
Heart drug developer Kardigan targets $1.4 billion valuation in US IPO Reuters
June 11, 2026 at 07:29 PMReliance lifts Indian shares after Meta data centre deal - Reuters
Reliance lifts Indian shares after Meta data centre deal Reuters
June 10, 2026 at 02:30 AM